This was confirmed through adding anti-IFN-γ and anti-TNF-α antibodies to stimulated NK cells prior to their utilization in tumor differentiation; the antibodies inhibited the upregulation of these markers on the cancer cells (Tseng et al., 2014, 2015a,b). The gene discussed is IFNG; the disease is neoplasm.